Mankind Pharma Q2 profit jumps 39% to ₹712 crore as revenue rises 17%

Mankind Pharma’s operating margin widened to 27% from 24.9% a year earlier. Its board also approved plans to merge two wholly owned subsidiaries into the company.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)